Search

Search Constraints

You searched for: Author/Creator Saeed, Anwaar

Search Results

1. Antacid exposure and immunotherapy outcomes among patients with advanced hepatocellular carcinoma. (April 2021)

2. Bemarituzumab in patients with FGFR2b-selected gastric or gastro-oesophageal junction adenocarcinoma (FIGHT): a randomised, double-blind, placebo-controlled, phase 2 study. Issue 11 (November 2022)

3. Clinical Outcome of Ampullary Carcinoma: Single Cancer Center Experience. (2nd May 2019)

4. Epidermal Growth Factor Receptor Inhibition in Epidermal Growth Factor Receptor–Amplified Gastroesophageal Cancer: Retrospective Global Experience. Issue 22 (1st August 2022)

6. Immunotherapy and Targeted Therapy for Advanced Gastroesophageal Cancer: ASCO Guideline. Issue 7 (1st March 2023)

7. Impact of corticosteroid therapy on the outcomes of hepatocellular carcinoma treated with immune checkpoint inhibitor therapy. Issue 2 (7th October 2020)

8. Impact of corticosteroid therapy on the outcomes of hepatocellular carcinoma treated with immune checkpoint inhibitor therapy. Issue 2 (7th October 2020)

9. Impact of corticosteroid therapy on the outcomes of hepatocellular carcinoma treated with immune checkpoint inhibitor therapy. Issue 2 (7th October 2020)

10. Impact of corticosteroid therapy on the outcomes of hepatocellular carcinoma treated with immune checkpoint inhibitor therapy. Issue 2 (7th October 2020)